Faculty

Professor Jarir At Thobari is a clinical pharmacologist and pharmacoepidemiologist at Universitas Gadjah Mada (UGM), Indonesia, where he leads the Clinical Epidemiology and Biostatistics Unit. He has extensive expertise in infectious diseases, including tuberculosis, dengue, COVID-19, and antimicrobial resistance.

He is actively involved in multi-centre clinical trials and vaccine research across the Asia-Pacific region, serving as Principal Investigator for several studies, including trials on the neonatal RV3-BB rotavirus vaccine. His work spans clinical trials, vaccine effectiveness, cost-effectiveness, and post-marketing safety through pharmacovigilance and data linkage systems.

Professor Jarir serves as Co-Lead of the Asia Pacific Vaccine Research Network and contributes to regional collaborations such as ARISE. He is also involved in national policy as a member of Indonesia’s Technical Advisory Group for Immunization (ITAGI) and the Health Technology Assessment committee, supporting evidence-based vaccine policy and regulatory evaluation.